A previous study has shown that in DLBCL cell lines, in addition to inhibiting the aggresomal pathway, HDAC6 inhibitors can also directly target the unfolded protein response (UPR) caused by excessive protein accumulation. Here, HDAC6 is linked to diffuse large B-cell lymphoma.